SEARCH

SEARCH BY CITATION

References

  • 1
    Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999. 17: 189220.
  • 2
    Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 1989. 47: 187376.
  • 3
    Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S., Functions of natural killer cells. Nat. Immunol. 2008. 9: 503510.
  • 4
    Maghazachi, A. A., Role of chemokines in the biology of natural killer cells. Curr. Top Microbiol. Immunol. 2010. 341: 3758.
  • 5
    Lanier, L. L., NK cell receptors. Annu. Rev. Immunol. 1998. 16: 359393.
  • 6
    Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K. and Kershaw, M. H., Activating and inhibitory receptors of natural killer cells. Immunol. Cell. Biol. 2011. 89: 216224.
  • 7
    Lanier, L. L., NK cell recognition. Annu. Rev. Immunol. 2005. 23: 225274.
  • 8
    Biron, C. A., Byron, K. S. and Sullivan, J. L., Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989. 320: 17311735.
  • 9
    Orange, J. S., Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 2006. 6: 399409.
  • 10
    Vossen, M. T., Biezeveld, M. H., de Jong, M. D., Gent, M. R., Baars, P. A., von Rosenstiel, I. A., van Lier, R. A. et al., Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella. J. Infect. Dis. 2005. 191: 198206.
  • 11
    Fodil-Cornu, N., Lee, S. H., Belanger, S., Makrigiannis, A. P., Biron, C. A., Buller, R. M. and Vidal, S. M., Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 2008. 181: 63946405.
  • 12
    Pyzik, M., Charbonneau, B., Gendron-Pontbriand, E. M., Babic, M., Krmpotic, A., Jonjic, S. and Vidal, S. M., Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. J. Exp. Med. 2011. 208: 11051117.
  • 13
    Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012. 481: 394398.
  • 14
    Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., Elford, A. R. et al., Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. USA 2012. 109: 12101215.
  • 15
    Su, H. C., Nguyen, K. B., Salazar-Mather, T. P., Ruzek, M. C., Dalod, M. Y. and Biron, C. A., NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 2001. 31: 30483055.
  • 16
    Soderquest, K., Walzer, T., Zafirova, B., Klavinskis, L. S., Polic, B., Vivier, E., Lord, G. M. et al., Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J. Immunol. 2011. 186: 33043308.
  • 17
    Kilbourne, E. D., Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006. 12: 914.
  • 18
    van den Wijngaard, C. C., van Asten, L., Koopmans, M. P., van Pelt, W., Nagelkerke, N. J., Wielders, C. C., van Lier, A. et al., Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS One 2012. 7: e31197.
  • 19
    Bearden, A., Friedrich, T. C., Goldberg, T. L., Byrne, B., Spiegel, C., Schult, P. and Safdar, N., An outbreak of the 2009 influenza a (H1N1) virus in a children's hospital. Influenza Other Respi. Viruses 2012. 6: 374379.
  • 20
    Bal, A., Suri, V., Mishra, B., Bhalla, A., Agarwal, R., Abrol, A., Ratho, R. K. et al., Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009–2010. Histopathology 2012. 60: 326335.
  • 21
    Brien, S., Kwong, J. C. and Buckeridge, D. L., The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine 2012. 30: 12551264.
  • 22
    Jose, P., Avdiushko, M. G., Akira, S., Kaplan, A. M. and Cohen, D. A., Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands. Exp. Lung Res. 2009. 35: 128.
  • 23
    Culley, F. J., Natural killer cells in infection and inflammation of the lung. Immunology 2009. 128: 151163.
  • 24
    Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J. et al., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006. 7: 517523.
  • 25
    Nogusa, S., Ritz, B. W., Kassim, S. H., Jennings, S. R. and Gardner, E. M., Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech. Ageing Dev. 2008. 129: 223230.
  • 26
    Stein-Streilein, J. and Guffee, J., In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 1986. 136: 14351441.
  • 27
    Hayakawa, Y. and Smyth, M. J., CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006. 176: 15171524.
  • 28
    Kane, K. P., Lavender, K. J. and Ma, B. J., Ly-49 receptors and their functions. Crit. Rev. Immunol. 2004. 24: 321348.
  • 29
    Dons'koi, B. V., Chernyshov, V. P. and Osypchuk, D. V., Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay. J. Immunol. Methods 2011. 372: 187195.
  • 30
    Zimmer, J., Andres, E. and Hentges, F., NK cell subsets and CD107a mobilization assay. Leukemia 2005. 19: 18491851.
  • 31
    Takeda, K., Nakayama, M., Sakaki, M., Hayakawa, Y., Imawari, M., Ogasawara, K., Okumura, K. et al., IFN-gamma production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. J. Leukoc. Biol. 2011. 90: 777785.
  • 32
    Weiss, I. D., Wald, O., Wald, H., Beider, K., Abraham, M., Galun, E., Nagler, A. et al., IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J. Interferon Cytokine Res. 2010. 30: 439449.
  • 33
    Jost, S., Reardon, J., Peterson, E., Poole, D., Bosch, R., Alter, G. and Altfeld, M., Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza. Immunology 2011. 132: 516526.
  • 34
    Kasai, M., Yoneda, T., Habu, S., Maruyama, Y., Okumura, K. and Tokunaga, T., In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature 1981. 291: 334335.
  • 35
    Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K. and Tamaoki, N., In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 1981. 127: 3438.
  • 36
    Abdul-Careem, M. F., Mian, M. F., Yue, G., Gillgrass, A., Chenoweth, M. J., Barra, N. G., Chew, M. V. et al., Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J. Infect. Dis. 2012. 206: 167177.
  • 37
    Hidalgo, L. G., Urmson, J. and Halloran, P. F., IFN-gamma decreases CTL generation by limiting IL-2 production: a feedback loop controlling effector cell production. Am. J. Transplant. 2005. 5: 651661.
  • 38
    Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A. et al., IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008. 14: 275281.
  • 39
    Guo, H. and Topham, D. J., Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 2010. 84: 77507759.
  • 40
    Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R. et al., Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008. 14: 282289.
  • 41
    de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J., Chau, T. N., Hoang, D. M. et al., Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006. 12: 12031207.
  • 42
    Perrone, L. A., Plowden, J. K., Garcia-Sastre, A., Katz, J. M. and Tumpey, T. M., H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008. 4: e1000115.
  • 43
    Szretter, K. J., Gangappa, S., Lu, X., Smith, C., Shieh, W. J., Zaki, S. R., Sambhara, S. et al., Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 2007. 81: 27362744.
  • 44
    Jost, S., Quillay, H., Reardon, J., Peterson, E., Simmons, R. P., Parry, B. A., Bryant, N. N. et al., Changes in cytokine levels and NK cell activation associated with influenza. PLoS One 2011. 6: e25060.
  • 45
    Du, N., Zhou, J., Lin, X., Zhang, Y., Yang, X., Wang, Y. and Shu, Y., Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J. Virol. 2010. 84: 78227831.
  • 46
    Wong, J. P., Christopher, M. E., Salazar, A. M., Dale, R. M., Sun, L. Q. and Wang, M., Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses. Vaccine 2007. 25: 31753178.
  • 47
    Lauzon, N. M., Mian, F., MacKenzie, R. and Ashkar, A. A., The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol. 2006. 241: 102112.
  • 48
    Cottey, R., Rowe, C. A. and Bender, B. S., Influenza virus. Curr. Protoc. Immunol. 2001. 42: 19.11.119.11.32.
  • 49
    Wahl, L. M., Wahl, S. M., Smythies, L. E. and Smith, P. D., Isolation of Human Monocyte Populations. Curr. Protoc. Immunol. 2006. 70: 7.6A.17.6A.10.
  • 50
    Kitaichi, N., Kotake, S., Morohashi, T., Onoe, K., Ohno, S. and Taylor, A. W., Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J. Leukoc. Biol. 2002. 72: 11171121.
  • 51
    Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T., Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 1997. 186: 16771687.
  • 52
    Salagianni, M., Lekka, E., Moustaki, A., Iliopoulou, E. G., Baxevanis, C. N., Papamichail, M. and Perez, S. A., NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses. J. Immunol. 2011. 186: 33273335.
  • 53
    Menachem, Y., Trop, S., Kolker, O., Shibolet, O., Alper, R., Nagler, A. and Ilan, Y., Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? Microbes Infect. 2005. 7: 825835.